Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy

Gastroenterology. 2000 Jun;118(6):1261-5. doi: 10.1016/s0016-5085(00)70379-9.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Angiotensin II / adverse effects*
  • Humans
  • Hypertension, Portal / drug therapy*
  • Hypertension, Portal / pathology*
  • Liver Circulation / drug effects
  • Liver Cirrhosis / drug therapy*
  • Liver Cirrhosis / pathology*
  • Vasoconstrictor Agents / adverse effects*

Substances

  • Vasoconstrictor Agents
  • Angiotensin II